Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/80065
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Use of serotonergic antidepressants and St John's wort in older Australians: A population-based cohort study |
Author: | Rahman, S. Basilakis, J. Rahmadi, A. Lujic, S. Musgrave, I. Jorm, L. Hay, P. Munch, G. |
Citation: | Australasian Psychiatry, 2013; 21(3):262-266 |
Publisher: | Informa Healthcare-Taylor & Francis |
Issue Date: | 2013 |
ISSN: | 1039-8562 1440-1665 |
Statement of Responsibility: | Syed Ziaur Rahman, Jim Basilakis, Anton Rahmadi, Sanja Lujic, Ian Musgrave, Louisa Jorm, Phillipa Hay, Gerald Münch |
Abstract: | OBJECTIVE: The study investigated the use of serotonergic antidepressants (SSRIs: selective serotonin reuptake inhibitors; SNRIs: serotonin–norepinephrine reuptake inhibitors) and St John’s wort in a large NSW-based community sample, and sought to identify a potentially dangerous concomitant use of these medications. METHODS: Cross-sectional data from 266,848 participants from the ‘45 and Up’ study were used. The questionnaire captures self-reported treatment for depression or anxiety and antidepressant medications in the last four weeks. RESULTS: 5.8% of participants received treatment for depression or anxiety, with 4.7% taking an SSRI and 1.3% an SNRI. St John’s wort was taken by 0.3% of the participants. Use of SSRIs and SNRIs was reported more frequently by females than males (respectively, 64.1% vs 35.9%, 66.9% vs 33.1%). The gender difference was even more pronounced for St John’s wort (75.6% vs. 24.4%). Use of antidepressants decreased after the age of 65 years. One hundred and forty people reported concurrent use of an SSRI and an SNRI, and 11 people of an SSRI with St John’s wort. CONCLUSIONS: Around 7% of the study population aged 45–65 years reported the use of SSRIs or SNRIs, decreasing to 5% above 70 years of age. It is of concern that some individuals used an SSRI concurrently with St John’s wort. |
Keywords: | antidepressants drug interactions Hypericum perforatum selective serotonin reuptake inhibitors serotonin–norepinephrine reuptake inhibitors St John’s wort |
Rights: | © The Royal Australian and New Zealand College of Psychiatrists 2013 |
DOI: | 10.1177/1039856213475681 |
Published version: | http://dx.doi.org/10.1177/1039856213475681 |
Appears in Collections: | Aurora harvest 4 Pharmacology publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.